Sanofi Institute for Biomedical Research Co., Ltd Posted June 9, 2026

R&D - Intrepide-Principal Scientist I, Biologics Discovery & Innovation - SZ

Suzhou (Jiangsu), China Full time
Drug Discovery & Preclinical Research Principal

Sanofi Institute for Biomedical Research Co., Ltd is the source of truth for this posting and owns the application process. We surface normalized context and market comparison you won't find on the original listing.

About this opportunity

Principal Scientist, Biologics Discovery & Innovation

Location:

Suzhou, China

Position Summary

We are seeking an accomplished Principal Scientist with broad biologics knowledge and technical leadership expertise to drive global R&D projects through internal–CRO hybrid models. In this role, you will be a subject-matter expert for biologics discovery, engineering, and relevant technology platforms, validating new approaches and ensuring accelerated program delivery in areas such as oncology, immunology, ophthalmology, or CNS. Success requires managing multidisciplinary teams and external resources, applying advanced scientific and project skills to validate and co-lead biologics programs from concept to key milestones.

This is a unique opportunity to operate at the intersection of scientific excellence and strategic execution. You will apply deep domain expertise to evaluate and champion emerging biologics technologies, translating scientific insights into tangible program milestones. Success in this role requires the ability to orchestrate multidisciplinary internal teams alongside external CRO resources, driving biologics programs from early concept through critical development milestones with rigor, agility, and collaborative leadership.

Key Responsibilities

1. Antibody Discovery Program Leadership

Serve as discovery lead or co-lead on critical antibody programs, overseeing the full arc from antigen design and immunization strategy through hit identification, screening, and lead selection.

Design and execute antigen engineering strategies, including recombinant protein design, hapten conjugation, and cell-based immunization approaches, to maximize the quality and diversity of immune responses.

Define clear program objectives, success criteria, and milestone plans to align cross-functional stakeholders and external discovery partners.

Oversee hybrid discovery workflows (internal + external) that integrate novel antibody technologies into therapeutic pipelines, proactively identifying and resolving bottlenecks to maintain program momentum.

2. Discovery Platform Expertise

Provide authoritative technical leadership across a broad range of antibody discovery platforms, including display screening for diverse antibody formats.

Lead and optimize single B cell cloning workflows campaigns, ensuring robust hit identification and efficient progression to lead candidates.

Guide teams on the scientific applicability, limitations, and optimal deployment of each discovery platform within the context of specific target biology and program requirements.

Stay at the forefront of the discovery field, continuously scanning the external landscape for breakthrough technologies and methodologies that could accelerate or differentiate the pipeline.

3. Advanced Antibody Modalities

Lead discovery campaigns for bispecific and multispecific antibodies, applying specialized screening and selection strategies tailored to complex, multi-target engagement requirements.

Evaluate and implement emerging modality-specific discovery approaches, ensuring the organization remains at the cutting edge of antibody format innovation.

4. CRO Management & Hybrid Workflow Execution

Strategically coordinate external CRO partnerships, defining project scopes, deliverables, quality standards, and timelines, to maximize operational efficiency and scientific output across discovery programs.

Serve as the primary interface between internal stakeholders and external discovery resources, ensuring seamless communication, alignment of objectives, and proactive resolution of technical or operational challenges.

Conduct regular performance reviews of CRO partners, driving continuous improvement and ensuring deliverables consistently meet internal quality and scientific standards.

5. Engineering-Supported Optimization & Innovation

Apply antibody engineering expertise, including affinity maturation, humanization, and liability assessment, as a supporting capability to advance discovery leads toward developable candidates.

Champion the adoption of innovative and transformative approaches, including AI-driven screening, machine learning-assisted design, and automated workflows, to meaningfully streamline and accelerate discovery-to-candidate progression.

Qualifications

Educational Background & Experience

Ph.D. in Immunology, Biochemistry, Bioengineering, or a closely related discipline; extensive industrial or advanced academic research experience strongly preferred.

5+ years of experience in antibody discovery, with demonstrated primary expertise in display technologies, B cell-based discovery, hit identification, and lead selection.

Proven experience in bispecific/multispecific antibody discovery and/or nanobody/VHH programs strongly preferred.

Demonstrated success managing complex, multi-stakeholder discovery programs, ideally involving CRO partnerships in a global and cross-cultural context.

Technical & Scientific Expertise, Discovery-Primary

Primary (Required): Deep, hands-on expertise in at least two of the following discovery platforms: phage display, yeast display, ribosome display, single B cell cloning, or hybridoma technology.

Primary (Required): Proven experience in antigen design and immunization strategy, with a track record of generating high-quality, diverse antibody hits against challenging targets.

Primary (Required): Strong hit identification and lead selection capabilities, including functional screening design, triage strategies, and lead nomination criteria.

Advanced Modalities (Strongly Preferred): Hands-on experience with bispecific/multispecific antibody discovery formats and/or nanobody/VHH discovery workflows.

Supporting (Complementary): Working knowledge of antibody engineering disciplines, affinity maturation, humanization, liability engineering, and developability optimization, to support lead progression.

Proven ability to critically evaluate, validate, and implement new discovery platforms or methodologies, consistently balancing scientific rigor with practical development timelines.

Strong track record of scientific contributions, including peer-reviewed publications, patents, or significant internal program milestones demonstrating creative problem-solving in antibody discovery.

Program & Collaboration Skills

Skilled and experienced in leading or co-leading cross-functional discovery teams, effectively aligning internal scientific capabilities with CRO deliverables and external partner commitments.

Strong organizational and project management abilities, with a consistent record of ensuring discovery milestones are met, risks are proactively managed, and resources are efficiently deployed.

Exceptional communicator who can fluently translate complex discovery science into clear, actionable plans for diverse stakeholders, including bench scientists, project managers, and senior leadership.

Innovation & Mentorship

Adept at identifying and working with novel solutions, such as AI-based antigen design, computational screening, and laboratory automation, to meaningfully accelerate discovery programs.

Deeply committed to developing scientific talent, generously sharing discovery expertise, and cultivating a team culture defined by continuous innovation, intellectual openness, and collaborative excellence.

 

Pursue progress , discover extraordinary

Better is out there. Better medications, better outcomes, better science. But progress doesn’t happen without people – people from different backgrounds, in different locations, doing different roles, all united by one thing: a desire to make miracles happen. So, let’s be those people.

At Sanofi, we provide equal opportunities to all regardless of race, colour, ancestry, religion, sex, national origin, sexual orientation, age, citizenship, marital status, ability or gender identity.

Watch our ALL IN video and check out our Diversity Equity and Inclusion actions at sanofi.com !

Job details

Seniority
Principal
Function
Drug Discovery & Preclinical Research
Therapeutic area
Not listed
Location
Suzhou (Jiangsu), China
Employment type
Full time

How this role compares

Computed from every other active Drug Discovery & Preclinical Research role in our database, not just this employer's listings.

We currently track 193 comparable Principal Drug Discovery & Preclinical Research roles across 31 biopharma companies.

193Comparable roles tracked
172Currently active
31Companies hiring similar roles
12Countries represented

Salary context

65 of 193 peers report a salary range (USD, annualized)

Peers share this role's job function and a matching or adjacent seniority level -- not necessarily the same therapeutic area or country.

This roleSubject Not listed on this posting
Peer group range $105,700 – $322,000 (median $165,300)

Where these roles are based

Top locations among the 193 comparable roles

United States159
India9
United Kingdom5
Canada4
China's Mainland3
Sweden3

+ 6 more countries

Seniority mix

193 of 193 peers have a known seniority level

Senior111
Principal56
Director26

Therapeutic area mix

29 of 193 peers have a known therapeutic area; the rest are genuinely unlabeled, not hidden

Oncology16
Immunology5
Cardiovascular / CVRM5
Neuroscience1
Respiratory1
Vaccines & Infectious Disease1

Similar opportunities

The closest matches from our peer group, ranked by how similar they are, not how well you'd qualify for them -- treat this as market context, not a guaranteed shortlist; a weak match is labeled as one below.

60%similar
Sanofi Institute for Biomedical Research Co., Ltd Suzhou (Jiangsu), China Principal
Same function Same seniority Same country
50%similar
Novartis Shanghai (Shanghai), China Director
Same function Adjacent seniority Same country
45%similar
AstraZeneca Gaithersburg, Maryland, United States of America Principal
Same function Same seniority
45%similar
Lilly Indianapolis, Indiana, United States of America Principal
Same function Same seniority
45%similar
Lilly Indianapolis, Indiana, United States of America Principal
Same function Same seniority
45%similar
Lilly San Francisco, California, United States of America Principal
Same function Same seniority

How we calculate "similar"

No black box, no LLM guesswork: a deterministic score built from four normalized attributes. Here's this role's own peer group at different match levels, so you can see the mechanism, not just the result.

Every comparison starts from the same 100-point budget: 25 for working in the same function, 40 for the same therapeutic area, 20 for the same or adjacent seniority, 15 for the same country. A dimension we can't confirm on both sides contributes nothing, never a guess, never a free pass.

60%
R&D - Intrepide - Principal Scientist I, Antibody Engineering - SZ
Sanofi Institute for Biomedical Research Co., Ltd · Suzhou (Jiangsu), China · Principal
Function Therapeutic area Seniority Country
45%
Advisor / Senior Advisor, CNS/PNS NAMs – Investigative Toxicology
Lilly · Indianapolis, Indiana, United States of America · Principal
Function Therapeutic area Seniority Country
45%
Advisor / Senior Advisor, Cardiovascular NAMs – Investigative Toxicology
Lilly · Indianapolis, Indiana, United States of America · Principal
Function Therapeutic area Seniority Country
45%
Principal /Senior Principal Scientist - Toxicology
Roche · Shanghai, Shanghai, China's Mainland · Principal
Function Therapeutic area Seniority Country
Unmatched or unknown dimensions score exactly the same: 0 points, never a partial guess. A role we know almost nothing about beyond its function bottoms out at 25%; it never inflates to 100% just because there's little to compare against. Seniority uses a defined ladder (Associate → Manager → Associate Director → Senior → Principal → Director → Senior Director → Executive/VP) so "Director" and "Senior Director" count as adjacent, but "Director" and "Executive/VP" do not.